To isolate p62, we used the v-abl-transformed murine Minato-ku, Tokyo-108 precursor B cell line 1-2 as starting material. When the Japan proteins of this cell were separated by electrophoresis, staining of the gel with anti-phosphotyrosine antibody showed that the major tyrosine-phosphorylated protein was a doublet, p62/64 ( Figure 1A ). Therefore, all of the Summary tyrosine-phosphorylated proteins from 5 ϫ 10 10 1-2 cells were purified together using the anti-phosphotyrosine A 62 kDa protein is highly phosphorylated in many monoclonal antibody, PY20, conjugated to agarose. cells containing activated tyrosine kinases. This proCoomassie blue-staining of a gel in which these proteins tein, characterized mainly by its avid association with were fractionated showed clear bands of p160 v-abl and rasGAP, has proved elusive. Anti-phosphotyrosine another probable breakdown products but only an indistibody was used to purify p62. From peptide sequence, tinct p62/64 ( Figure 1B) . Apparently, p62/64 is much molecular cloning revealed a cDNA encoding a novel more heavily tyrosine-phosphorylated than v-Abl and is protein, p62 dok , with little homology to others but with therefore quite evident by anti-phosphotyrosine staining a prominent set of tyrosines and nearby sequences but not by protein staining. The indistinct bands of p62 suggestive of SH2 binding sites. In cells, v-Abl tyrosine and p64 were excised from gels (about 8 g of p62 kinase binds and strongly phosphorylates p62 dok , and 3 g of p64), and the proteins were cleaved with which then binds rasGAP. A monoclonal antibody, 2C4, lysylendopeptidase in the gel, eluted, and subjected to to the rasGAP-associated p62 reacts with p62 dok
Introduction to micropeptide sequencing to obtain six independent peptide sequences (underlined in Figure 2A ). Degener-A 62 kDa protein (p62) that is associated with the p120 Ras GTPase activating protein (rasGAP) was originally ate primers representing sequences ALAQTENQP of peptide II and KVGQAQDIL of peptide IV were used to identified as a common target of protein-tyrosine kinases v-Abl, v-Src, v-Fps, v-Fms, and activated EGF amplify a cDNA from 1-2 cell RNA by polymerase chain reaction (PCR), producing a 422 base pair (bp) cDNA. receptor (Ellis et al., 1990) . Tyrosine phosphorylation of p62 correlates with transforming activity of the viral Nucleotide sequence revealed an open reading frame encoding peptides II, IV, and III ( Figure 2A ), indicating oncogene products as well as Bcr-Abl, a causative tyrosine kinase of human chronic myelogenous leukemia that it is a partial cDNA of p62. Screening of a mouse spleen cDNA library yielded a clone with a 1749 bp insert (Koch et al., 1989; Moran et al., 1990; Bouton et al., 1991; Muller et al., 1991; DeClue et al., 1993; Parmar containing 1446 bp of open reading frame (ORF) initiated at an ATG codon fitting the Kozak consensus and Rosenberg, 1996) . A p62 is also rapidly tyrosinephosphorylated upon PDGF-, CSF-1-, Insulin-, IGF-, and (GCCATGG) (Kozak, 1986) . The 482 amino acid sequence of the deduced protein product had all six pep-VEGF-stimulation of cells (Heidaran et al., 1992; Hosomi et al., 1994; Guo et al., 1995; Sanchez-Margalet et al., tide sequences from purified p62 ( Figure 2A ). Although the length of 482 amino acids is less than might be 1995). Stimulation of B cell receptors or Fc␥ receptors (type IIIA; CD16), both of which are coupled with cytoexpected for a 62 kDa protein, the tyrosine-phosphorylated product translated from the cDNA comigrates with solic tyrosine kinases, also induces tyrosine phosphorylation of a p62 (Gold et al., 1993; Darby et al., 1994) .
the endogenous tyrosine-phosphorylated p62 of 1-2 cells (see Figure 3B ). Thus, the cDNA probably contains Assuming that all of these are the same p62, these data strongly suggest that p62 plays a central role in signaling the entire coding region of p62 mRNA. Since the deduced amino acid sequence of p62 does not match mediated by a wide range of tyrosine kinases. However, characterization of p62 has awaited molecular cloning.
any known protein sequence, we designate the novel genetic locus for p62 the dok gene (downstream of tyro-A cDNA reported to encode rasGAP-associated p62 turned out to encode Sam68, a protein distinct from p62 sine kinases). By Northern blot analysis with a mouse multiple-tissue that is a substrate of tyrosine kinases (Wong et al., 1992; Fumagalli et al., 1994; Taylor and Shalloway, 1994; Lock blot , only a 1.9 kb dok mRNA was detected ( Figure 2B ). This agreed with the size of our clone, assuming a poly (A) et al., 1996) . Here, we report cloning of a cDNA encoding mouse p62. The protein, p62 dok , is tyrosine-phosphorytail of about 100-200 bases. Expression of the gene is widespread, except in brain and testis. lated when coexpressed with Abl and then binds to al., 1996) . An entire PTB domain is not evident from the sequence, and PTB domains are structurally close relatives of PH domains (Zhou et al., 1995; Eck et al., 1996; Harrison, 1996; Lemmon et al., 1996) , making it uncertain whether this homology suggests that p62 dok can interact with other phosphotyrosine-containing proteins. p62 dok has several potential target sites for serine/ threonine kinases such as PKC (S14, T25, S331), MAPK (S33, S147), CK-II (T274), and Cdk2 (S415) but has no apparent myristoylation or palmitylation sites. Overall, the protein is relatively rich in serines and threonines (15%). A C-terminal 145 amino acid stretch (P280 to P424) is very rich in proline residues (21.4%), while the rest of the protein has relatively few (4.4%).
Songyang, Cantley, and their colleagues have defined the peptide sequences that are preferential substrates of many tyrosine kinases (Songyang et al., 1995) . In general, cytosolic kinases like Abl and Src selectively phosphorylate peptides of the
, there are several apparent target sites for cytosolic kinases but not ones for receptor kinases ( Figure 2A ). This is consistent with the observation that rasGAP-associated p62 is phosphorylated in cells with activated cytosolic kinases such as v-Src and v-Abl and suggests that the protein is a direct substrate of the kinases. Upon cell surface-receptormediated signaling, p62 dok may be phosphorylated by the kinases (Figure 2A ) (Songyang et al., 1993; Songyang (B) Phosphotyrosine-containing proteins purified from 1-2 cells.
et al., 1995) . This suggests that once phosphorylated, Proteins purified from 1 ϫ 10 9 1-2 cells (1-2) and 0. for Abl phosphorylation of p130 Cas Pawson, 1995) . This could explain the prominent tyrosine phosphorylation of p62 dok upon tyrosine kinaseAlthough database searches found no striking homolmediated signaling. ogy to known proteins in the p62 dok sequence, two partial The previous suggestion that the rasGAP-SH2 dohomologies were detected. One is a potential PH (pleckmain directly binds to tyrosine-phosphorylated p62 dok strin homology) domain at the N terminus detected by implies the existence of a rasGAP-SH2 target site of the a profile search (previously noted in human Dok by Carform pYxxP (Mayer et al., 1992; Songyang et al., 1993 Songyang et al., ) pino et al. (1996 see adjoining paper) (Figure 2A ). PH (Z. Songyang, personal communication) . Among the 15 domains may be involved in the membrane localization tyrosine residues in p62 dok , six have the requisite proline of proteins (Lemmon et al., 1996) . The second is a short at ϩ3 (Figure 2A ). pYxxP is also a preferential target site homology between p62 dok and insulin receptor subfor the SH2 domains of Abl and Crk (Songyang et al., strate-1 (IRS-1) detected by a BLAST search (Sun et al., 1993) . Moreover, p62 dok has other potential SH2 target 1991). It covers part of the PTB domain of IRS-1 (Figure sites ( Figure 2A ). All except one (Y 340 GHV/mouse to 2C), which binds phosphotyrosine-containing motifs of Y
341
EHA/human) of these SH2 target sites are conserved the form NPXpY (He et al., 1995; Wolf et al., 1995; Eck 100% in human Dok (see adjoining paper, Carpino et et al., 1996; Harrison, 1996) . The PTB-like sequence of al. , 1996) . Thus, p62 dok may function as a docking protein mouse Dok is conserved 100% in human Dok, whereas for tyrosine kinase-mediated signaling, as proposed for overall amino acid identity between mouse and human IRS-1 upon insulin stimulation (Myers et al., 1994) . Dok is 83% (see adjoining paper, Carpino et al., 1996) .
Multiply tyrosine-phosphorylated p62 dok might recruit In addition, a similar sequence was found in peptide SH2-containing signaling molecules to the membrane sequences encoded by mouse and human EST (exfraction of cells, where the rasGAP-p62 dok complex is pressed sequence tag) cDNA clones, AA008417 and preferentially localized (Moran et al., 1991) . It has been T09328 ( Figure 2C ). Interestingly, the two arginine resisuggested that only 10-25% of tyrosine-phosphorylated dues of IRS-1, which interact directly with the phosphop62 dok is associated with rasGAP (Bouton et al., 1991; Moran et al., 1991) and that phospholipase C-␥1 and tyrosine, are conserved in p62 dok and the ESTs (Eck et (Eck et al., 1996) . Identical and similar (ϩ) residues in each alignment are indicated.
p50
csk may also be associated with p62 dok , probably (Duyster et al., 1995; Pawson, 1995) . These data strongly suggest that p62 dok is directly and through their SH2 (Maa et al., 1994; Neet and Hunter, 1995) . multiply phosphorylated by v-Abl in vivo. To our surprise, p62 dok is also highly tyrosine-phosphorylated To study the interaction of p62 dok with rasGAP, we performed a transient expression assay using 293 cells when coexpressed with exogenous c-Abl, although c-Abl does not autophosphorylate ( Figure 3A ). These as recipient. First, we verified that p62 dok gets phosphorylated by v-Abl. As expected, both p62 dok and data with overexpressed c-Abl might imply a role of p62 dok in the normal function of Abl kinase, but further influenza hemagglutinin-epitope-tagged (HA-tagged) p62 dok were heavily tyrosine-phosphorylated when coexexamination of this question is needed. rasGAP-associated p62 has previously been conpressed with v-Abl ( Figure 3A) . The phosphorylated form of p62 dok and HA-tagged p62 dok migrated at 62/64 kDa fused with the Sam68 protein (Lock et al., 1996) . Roth and his colleagues raised a monoclonal antibody, 2C4, and p63/65 kDa, respectively ( Figure 3A) . The 62/64 kDa doublet of phosphorylated p62 dok from transfected 293 against the p62 and separated it from Sam68 Ogawa et al., 1994; Neet and Hunter, 1995) . cells comigrated with the tyrosine-phosphorylated 62/ 64 kDa doublet of endogenous p62 dok from 1-2 cells 2C4 recognizes tyrosine-phosphorylated p62, at least in v-src-transformed cells and in insulin-stimulated cells. (Figure 3B ). The unphosphorylated form of HA-tagged p62 dok migrated at about 61 kDa, indicating that tyrosine To ascertain whether the protein recognized by 2C4 was the same one as ours, we obtained the antibody and phosphorylation of p62 dok causes a mobility shift and also that nearly 100% of the HA-tagged p62 dok is phosused it to immunoprecipitate p62 dok . It precipitated HAtagged p62 dok , whereas monoclonal antibody to Sam68 phorylated by v-Abl ( Figure 3A) . Furthermore, v-Abl is coprecipitated with HA-tagged p62 dok , indicating that did not ( Figure 3D ). This indicates that the rasGAP-associated p62 in v-src-transformed cells and in insulin-stimv-Abl forms a stable complex with p62 dok in vivo ( Figure  3C ), as suggested previously (Mayer et al., 1992 ) and ulated cells is p62 dok or its immunologically related protein. In fact, p62
dok was heavily tyrosine-phosphorylated predicted by the processive phosphorylation model Next, we examined whether p120 rasGAP forms a phorylated p62 dok was bound in vitro to the N-terminal SH2 of rasGAP fused with glutathione S-transferase stable complex with p62 dok . Endogenous rasGAP of 293 cells was efficiently coimmunoprecipitated with HA-(GST) but not to its SH3 fusion protein ( Figure 3F ). That mice lacking p120 rasGAP show vascular defects tagged p62 dok when coexpressed with v-Abl ( Figure 3E ). However, rasGAP was not coimmunoprecipitated with and aberrant apoptosis of neural cells underscores the physiological significance of the protein (Henkemeyer p62 dok without expression of v-Abl. This indicates that et al., 1995). Recently, Parmar and Rosenberg reported partners. How these many adapter and docking proteins act in the cellular economy is uncertain, but the knowlthat the lymphoid-transforming activity of v-abl variants that do not induce either tyrosine phosphorylation of edge that cytoplasmic tyrosine kinases have such docking proteins as major substrates suggests that they are p62 dok or rasGAP is restored by coexpression of v-ras (Parmar and Rosenberg, 1996) . This suggests that p62 dok a key to understanding both the normal and oncogenic activities of these kinases. and/or rasGAP could be a link between v-Abl and the Ras pathway, one that is essential in tyrosine kinaseExperimental Procedures mediated signaling. Because rasGAP is a negative regulator of Ras and transient expression of Bcr-Abl downCell Culture and Monoclonal Antibodies modulates cellular rasGAP activity (Skorski et al., 1994) is that the 2C4 antibody Holgado et al., 1996) . IRS-1-deficient mice g of template cDNA prepared from 1-2 cells, using 43 amplification showed impaired biological responses to insulin and cycles (95ЊC for 30 s, 58ЊC for 10 s, 1 min ramp to 72ЊC, 72ЊC for IGF-1 stimulation (Araki et al., 1994; Tamemoto et al., 10 s), producing a 422 bp cDNA. Using this PCR product as a 1994).
probe, 3 ϫ 10 6 plaques prepared from mouse spleen cDNA library
The various known docking proteins contain putative (Stratagene) were screened to obtain 12 independent positive clones. Of the 12 clones, four clones had a cDNA insert longer than SH2 binding sites of variable specificity. For instance, 1700 bp, the longest being 1749 bp.
IRS-1 and IRS-2 contain many YxxM motifs, the target site of the PI-3 kinase SH2, whereas Cas, Sin/Efs, and phorylated Cas and Sin/Efs do bind Crk Alexandropoulos and Baltimore, 1996) . These
Expression Plasmids
findings suggest that each docking protein may have the p160 v-abl and p140 c-abl (type IV) expression plasmids, pGD-v-abl and specificity to recruit a particular set of SH2-containing pPLcIV, respectively, were generated as described (Jackson and proteins to induce appropriate biological responses. Baltimore, 1989; Scott et al., 1991 (1994) . Versagated GST-fusion protein carrying rasGAP N-terminal SH2 or SH3 tile retroviral vectors for potential use in gene therapy. Gene Ther. domain (Santacruz) at 4ЊC for 3 hr. The resulting complexes were 1, 136-138. washed five times with TNN buffer, then subjected to immunoblot analysis with monoclonal antibody to phosphotyrosine (see above).
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